BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iovene MR, Pota V, Galdiero M, Corvino G, Di Lella FM, Stelitano D, Passavanti MB, Pace MC, Alfieri A, Di Franco S, Aurilio C, Sansone P, Niyas VKM, Fiore M. First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review. World J Clin Cases 2019; 7(21): 3535-3548 [PMID: 31750335 DOI: 10.12998/wjcc.v7.i21.3535]
URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3535.htm
Number Citing Articles
1
Adrienn Hanczvikkel, Ákos Tóth, Irén Anna Kopcsóné Németh, Orsolya Bazsó, Lőrinc Závorszky, Lilla Buzgó, Virág Lesinszki, Dániel Göbhardter, Erika Ungvári, Ivelina Damjanova, Attila Erőss, Ágnes Hajdu. Nosocomial outbreak caused by disinfectant-resistant Serratia marcescens in an adult intensive care unit, Hungary, February to March 2022 Eurosurveillance 2024; 29(26) doi: 10.2807/1560-7917.ES.2024.29.26.2300492
2
Qian Xu, Beiwen Zheng, Kaixuan Li, Ping Shen, Yonghong Xiao. A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivoBMC Genomics 2024; 25(1) doi: 10.1186/s12864-023-09904-2
3
Marco Fiore, Aniello Alfieri, Sveva Di Franco, Maria Caterina Pace, Vittorio Simeon, Giulia Ingoglia, Andrea Cortegiani. Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-AnalysisAntibiotics 2020; 9(7): 388 doi: 10.3390/antibiotics9070388
4
A. V. Nevezhina. Carbapenemases as factors of Resistance to Antibacterial DrugsActa Biomedica Scientifica (East Siberian Biomedical Journal) 2021; 5(6): 95 doi: 10.29413/ABS.2020-5.6.11
5
Negin Bolourchi, Narjes Noori Goodarzi, Christian G. Giske, Shoeib Nematzadeh, Fatemeh Haririzadeh Jouriani, Hamid Solgi, Farzad Badmasti. Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strainsGene 2022; 822: 146355 doi: 10.1016/j.gene.2022.146355
6
Maria Caterina Pace, Antonio Corrente, Maria Beatrice Passavanti, Pasquale Sansone, Stephen Petrou, Sebastiano Leone, Marco Fiore. Burden of severe infections due to carbapenem-resistant pathogens in intensive care unitWorld Journal of Clinical Cases 2023; 11(13): 2874-2889 doi: 10.12998/wjcc.v11.i13.2874
7
Ákos Tóth, Attila Makai, Laura Jánvári, Ivelina Damjanova, Márió Gajdács, Edit Urbán. Characterization of a rare blaVIM-4 metallo-β-lactamase-producing Serratia marcescens clinical isolate in HungaryHeliyon 2020; 6(6): e04231 doi: 10.1016/j.heliyon.2020.e04231
8
Faviola Tavares-Carreon, Karla De Anda-Mora, Idalia C. Rojas-Barrera, Angel Andrade. Serratia marcescens antibiotic resistance mechanisms of an opportunistic pathogen: a literature reviewPeerJ 2023; 11: e14399 doi: 10.7717/peerj.14399
9
Alessandra Piccirilli, Sabrina Cherubini, Fabrizia Brisdelli, Paolo Fazii, Andrea Stanziale, Susanna Di Valerio, Valentina Chiavaroli, Luigi Principe, Mariagrazia Perilli. Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU)Diagnostics 2022; 12(9): 2180 doi: 10.3390/diagnostics12092180